Metropolitan Life Insurance Company (MetLife)’s Rocket Lab Corp RKLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,922
Closed -$61.3K 1679
2024
Q1
$61.3K Sell
14,922
-1,243
-8% -$5.74K ﹤0.01% 1300
2023
Q4
$89.4K Hold
16,165
﹤0.01% 1147
2023
Q3
$70.8K Buy
16,165
+830
+5% +$5.05K ﹤0.01% 1203
2023
Q2
$92K Buy
15,335
+4,693
+44% +$21.5K ﹤0.01% 1057
2023
Q1
$43K Sell
10,642
-2,731
-20% -$12.3K ﹤0.01% 1476
2022
Q4
$50.4K Hold
13,373
﹤0.01% 1466
2022
Q3
$54.4K Hold
13,373
﹤0.01% 1411
2022
Q2
$50.7K Buy
+13,373
New +$78.7K ﹤0.01% 1498

Other funds holding RKLB

Metropolitan Life Insurance Company (MetLife)'s RKLB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Rocket Lab Corp (RKLB) in Q2 2024, closing a stake of 14,922 shares — an estimated $61.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RKLB in Q2 2022 and held it in 8 quarters. The position peaked at $92K in Q2 2023. 240 funds tracked by Wall St. Rank hold RKLB as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Rocket Lab Corp position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 14,922 Rocket Lab Corp shares in Q2 2024, an estimated $61.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Rocket Lab Corp in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Rocket Lab Corp position peaked at $92K in Q2 2023.
  • 240 funds tracked by Wall St. Rank held Rocket Lab Corp as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.